SCHEMBL21597699

SCHEMBL21597699

CCOC(=O)c1c(NC(=O)C2CC2)sc2c1CCCO2

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.57
MAPT P10636 8/20 0.57
LMNA P02545 1/20 0.57
HPGD P15428 3/20 0.57
MAPK1 P28482 1/20 0.57
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 5/20 0.52
HSD17B10 Q99714 2/20 0.52
POLB P06746 3/20 0.51
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
HTT P42858 1/20 0.51
GAA P10253 2/20 0.50
HIF1A Q16665 1/20 0.50
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46
CXCR2 P25025 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21597600 0.82 FLT3 (0.49) ALDH1A1MAPTHPGDKMT2AKDM4E
SCHEMBL5451004 0.81 MAPT (0.77) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL7537079 0.79 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL5450569 0.79 KMT2A (0.69) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL21597594 0.79 ALDH1A1 (0.61) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL21597242 0.79 ALDH1A1 (0.68) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL21603868 0.79 MAPT (0.58) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL3806687 0.77 MAPT (0.77) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL5455639 0.77 KMT2A (0.58) ALDH1A1MAPTLMNAHPGDMAPK1
SCHEMBL5460238 0.77 CNR2 (0.64) ALDH1A1MAPTLMNAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE UCB Biopharma SRL (BE) 2024-06-25 US disclosed
EP-3810606-A1 THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE UCB Biopharma SRL (BE) 2021-04-28 EP disclosed
CN-112566910-A Thiophene derivatives for the treatment of IgE induced diseases UCB生物制药有限责任公司 2021-03-26 CN disclosed
WO-2019243550-A1 THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE UCB Biopharma SRL (BE) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE TSLP, CYSLTR1, CYSLTR2 ALDH1A1 233/4885MAPT 2356/4885LMNA 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.